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Abstract
Eukaryotic chromosomes terminate in telomeres, complex nucleoprotein structures that are required for chromosome
integrity that are implicated in cellular senescence and cancer. The chromatin at the telomere is unique with characteristics
of both heterochromatin and euchromatin. The end of the chromosome is capped by a structure that protects the end and
is required for maintaining proper chromosome length. Immediately proximal to the cap are the telomere associated
satellite-like (TAS) sequences. Genes inserted into the TAS sequences are silenced indicating the chromatin environment is
incompatible with transcription. This silencing phenomenon is called telomeric position effect (TPE). Two other silencing
mechanisms have been identified in eukaryotes, suppressors position effect variegation [Su(var)s, greater than 30 members]
and Polycomb group proteins (PcG, approximately 15 members). We tested a large number of each group for their ability to
suppress TPE [Su(TPE)]. Our results showed that only three Su(var)s and only one PcG member are involved in TPE,
suggesting silencing in the TAS sequences occurs via a novel silencing mechanism. Since, prior to this study, only five genes
have been identified that are Su(TPE)s, we conducted a candidate screen for Su(TPE) in Drosophila by testing point
mutations in, and deficiencies for, proteins involved in chromatin metabolism. Screening with point mutations identified
seven new Su(TPE)s and the deficiencies identified 19 regions of the Drosophila genome that harbor suppressor mutations.
Chromatin immunoprecipitation experiments on a subset of the new Su(TPE)s confirm they act directly on the gene inserted
into the telomere. Since the Su(TPE)s do not overlap significantly with either PcGs or Su(var)s, and the candidates were
selected because they are involved generally in chromatin metabolism and act at a wide variety of sites within the genome,
we propose that the Su(TPE) represent a third, widely used, silencing mechanism in the eukaryotic genome.
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Introduction
The proper development and health of an organism are the
result of a complex interplay between regulatory systems that
activate genes whose functions are necessary, and those that
repress the activity of genes whose functions are not required.
Defects in either transcriptional activation or silencing can have
very severe consequences leading to various pathologies including
cancer. Over the past several decades, extensive research has
focused on the mechanisms involved in gene activation. More
recently, several laboratories, including ours, have begun to dissect
the regulatory systems that silence gene expression.
At least two mechanistically distinct repression systems have
been described that are widely used in multi-cellular eukaryotes.
The best described involves a group of about 15 proteins known as
the Polycomb group (PcG) [1–5]. The PcG of proteins are
required to repress the activity of homeotic genes, the loci that
maintain segment identity, in body segments where their activity is
not required. Mutations in the PcG genes can lead to expression of
the homeotic loci in the wrong body segments resulting in
duplications or deletions of body parts. However, the repressive
functions of the PcG proteins are not restricted to homeotic loci.
Numerous studies have shown the PcG proteins bind to and
regulate many other loci in the genome [2,6]. The mechanism of
action of the majority of PcG proteins remains unknown. Some,
such as E(z), are in involved in complexes that modify nucleosome
structure through methylation of H3K27 [7–11]. For the majority
of the PcG proteins, the only clues to their functions come from
experiments that show they bind to the promoters and to
regulatory regions upstream of and within target genes. It is
widely believed they create or promote an alteration in chromatin
structure that represses transcription, but their mechanism(s) of
action remain enigmatic [1–4].
A second repressive system has been identified through analysis
of mutations that affect a phenomenon called position effect
variegation (PEV) [12–17]. PEV occurs when a gene, normally
located in euchromatin, is relocated close to a broken segment of
heterochromatin. In some cells the gene is expressed normally, but
in others, its activity is completely silenced. Our lab, and others,
have conducted genetic screens for dominant mutations that
suppress this gene silencing [Su(var)s] [18–23]. Between 30 and 50
loci can be mutated to produce the Su(var) phenotype. Only about
a dozen of the Su(var)s have been cloned. Like the PcG of proteins,
their mechanism of action remains largely unknown. Some of the
Su(var)s are involved in modifying nucleosome structure by
deacetylation (HDAC1/RPD3) [24] or methylation of H3K9
[SU(VAR)3-9] [25,26], modifications associated with transcriptional
silencing. Others may be structural components that appear to be
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[HP1a aka SU(VAR)2-5] [27–30]. Although these genes were
identified because they disrupt silencing associated with hetero-
chromatin (PEV), many of them are components of a silencing
mechanism employed at euchromatic sites throughout the genome
[31–35]. Fine scale localization studies indicate the Su(var)s
localize to the promoter, as might be expected, but they are also
found in the coding regions of genes [31] (unpublished
observations).
Since both groups of proteins are involved in gene silencing one
might expect there to be a significant overlap between the two
groups. Surprisingly this is not the case. Several years ago, we
examined a number of Su(var) mutations for homeotic effects and
a number of PcG mutations for an effect on PEV. None of the
Su(var)s cause homeotic transformations and only one of the PcG
proteins [E(Pc)] suppresses PEV [36]. Thus, the Su(var)s and PcG
appear to identify two distinct eukaryotic gene silencing mecha-
nisms.
A third, and much less studied, silencing phenomenon is
telomeric position effect (TPE). TPE silencing occurs when a
normally euchromatic gene is inserted into the telomere of a
eukaryotic chromosome [37–42]. The gene is expressed in some
cells of the tissue in which it should be expressed and is repressed
in others, resulting in a mosaic phenotype. Since PEV and TPE
both display a variegated phenotype, they are often thought to be
variations on the same theme, and thus represent a similar, if not
nearly identical, silencing phenomenon. However, careful exam-
ination of the phenotypes reveals some subtle differences. For
example, the white (w
+) gene in Drosophila, one of the genes
responsible for the bright red eye of the fruit fly, can be subject to
both PEV and TPE. In all cases where the w
+ gene is subject to
PEV, the fly eye is a mosaic of white and red eye facets, suggesting
the w
+ gene is either expressed normally or completely repressed.
On the other hand, in some instances where the w
+ gene is subject
to TPE, the fly’s eye is a uniform pale yellow with occasional red
facets. This suggests that TPE very strongly reduces, but does not
completely abolish, transcription levels in most cells and that
occasional cells escape repression altogether. Whether this subtle
phenotypic difference in the tertiary eye phenotype is meaningful
in terms of the mechanism of PEV versus that of TPE is unknown.
Given the phenotypic similarities between TPE and PEV, one
might expect that many of the proteins involved in PEV would be
involved in TPE. Prior to this study, this hypothesis had only been
tested in a very limited manner. Cryderman et al. [38] examined
the effects of mutations in two Su(var) genes, HP1a and Su(var)2-1,
and found they had no effect on TPE. They also found that the
addition of an extra Y chromosome, a classical suppressor of PEV,
had no effect on TPE. The only Su(var) mutation shown to
suppress TPE was a single allele of Su(var)3-9 recovered in a screen
for suppressors of TDA-PEV [43]. Thus, although the sample size
is small, it appears the mechanisms underlying PEV and TPE may
differ.
Similar studies have asked whether mutations in PcG proteins
are dominant or dosage sensitive suppressors of TPE [38,44,45]. A
study by Boivin et al. [44] found no clear dominant suppressors of
TPE among a large set of PcG mutations. The only exceptions
were polyhomeotic proximal (ph-p), which was a recessive suppressor,
and perhaps Posterior sex combs (Psc). Psc
1, the only allele tested,
dominantly suppressed some telomeric inserts but not others.
Earlier studies had shown the some Psc alleles were dominant
suppressors while others had no effect on TPE [38]. The absence
of dominant or dosage sensitive suppressors of TPE in the PcG
suggests TPE and PcG mediated silencing may differ in a
fundamental manner.
The components of the mechanism that cause TPE are largely
unknown. The only systematic search for mutations that suppress
TPE [Su(TPE)] employed a set of very large deficiencies to screen
for dosage sensitive loci in Drosophila [45]. Several regions in the
Drosophila genome were identified that contain Su(TPE)s,
however the loci responsible for modifying TPE have not been
further localized, and none were examined for their affect on PEV
or PcG associated silencing.
The telomeres of most eukaryotic chromosomes adopt a
specialized nucleoprotein structure that consists of two regions
[46–48]. At the extreme terminus is a tandem array of GC rich
repeats that forms a complex structure required for proper
maintenance of the end of the chromosome. It is required for at
least two essential functions: 1) a reverse transcriptase (telomerase)
based system that maintains telomere length, and 2) a cap to
protect the chromosome end from degradation, recombination
and end-joining reactions (telomere fusions). In this terminal
region, Drosophila telomeres differ from most other eukaryotes.
Rather than tracts of GC rich regions, Drosophila termini consist
of tandem repeats of the retrotransposons, HeT-A, TART and
TAHRE [49,50]. Drosophila employs periodic transposition of the
retrotransposons, also a reverse transcriptase mechanism, to
maintain correct telomere length.
Immediately adjacent to the extreme terminus of eukaryotic
chromosomes is a structurally distinct region that consists of a
mosaic of repeated sequences, known as the telomere associated
satellite-like (TAS) sequences. All eukaryotic organisms, including
Drosophila, have subtelomeric repeats [48,50]. These sequences
are highly polymorphic among different chromosome ends and
different individuals. This high degree of polymorphism is
indicative of a dynamic turnover of sequences and there is no
obvious relationship between sequences of the subtelomeric
repeats across species. In spite of the sequence variation, the
ubiquitous presence of subtelomeric repeat regions in all
eukaryotes suggests there are shared functional constraints that
require this structure, or a similar underlying process exists that
leads to its generation and maintenance [48]. However, until
recently, little progress has been made in determining the structure
or function of the subtelomeric repeat region or a process that
would create and maintain it.
TPE has only been observed when a reporter gene inserts into
the TAS sequences suggesting the observed gene repression is a
consequence of chromatin conformation of the TAS region of the
chromosome. For many years it was thought the TAS sequences
adopt a heterochromatin-like conformation [17,38,50–52] that
acts as a buffer between the chromosome termini and euchromatic
regions. This assumption was based on the observations that TAS
regions have many of the characteristics of centromeric hetero-
chromatin: 1) they are darkly stained throughout the cell cycle
indicating dense compaction; 2) they are late replicating; 3) they
have lowered accessibility to nucleases; 4) they are gene poor; and
5) reporter genes inserted into this region are silenced (TPE).
However, more recent experiments [53] have shown that the
subtelomeric repeat regions are not as compacted as centromeric
heterochromatin and are not as late replicating. In addition,
employing antibodies, the authors demonstrated that chromatin
proteins normally found in the euchromatic regions of the genome
(such as JIL-1 and Z4) and histone modifications associated with
active chromatin (such as trimethylated H3K4) are found in the
subtelomeric repeat regions. On the other hand, histone
modifications normally found in heterochromatin (such as H3K9
and H4K20 trimethylation) are also present. In addition, some
members of the Polycomb Group (PcG) were also localized to the
region [44,53]. Thus, the TAS regions may represent a 3
rd type of
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matin and euchromatin.
Prior to the present work, only five loci had been identified in
metazoans that, when mutated, suppress TPE [Su(TPE)]: Posterior
sex combs (Psc) (a PcG protein); Suppressor of zeste (2) [Su(z)2] [38];
Su(var)3-9 (a Su(var) protein) [43]; ataxia telangiectasia mutated (atm)
[54] and grappa (gpp) [55]. However, the telomere is a complex
nucleoprotein structure where, for example, it has been estimated
that greater than 40 proteins are involved in the capping function
alone [56]. This suggests the actual number of genetic factors
involved in establishing the chromatin architecture of the telomere
and/or in TPE may be far greater than the five genes identified to
date.
We began our analysis of TPE by systematically determining the
extent of the overlap between the silencing mechanisms involved in
PEV and TPE. We did so by testing more than 20 Su(var) loci for
their ability to suppress TPE and found only about 20% of the
Su(var)s suppressed TPE. This result suggests the repression that
occursatthetelomereiscausedbya silencingmechanism that differs
substantially from that employed in PEV, and silencing at the
telomere will involve an, as yet, unidentified suite of factors. It was
impossible to adequately test whether Su(TPE) were also Su(var)
because only five loci had been identified that suppress TPE.
Accordingly, we conducted a ‘‘candidate screen’’ to identify
additional loci involved in the gene silencing associated with TPE.
We tested the effect of single gene mutations in, or small
deficiencies for, genes that encoded proteins known, or suspected,
to be involved in chromatin structure or nuclear architecture. The
screen produced 27 new candidate Su(TPE)s: seven identified by
point mutations, a combination of point mutations and deficien-
cies or molecularly; and 20 by deficiencies alone. To assess the
degree of overlap between TPE and PEV, we tested all of the
Su(TPE) candidates for their ability to suppress PEV. We found
that only about 20% of the Su(TPE) candidates also suppressed
PEV. The observation that there is only a small overlap between
the Su(TPE)s and Su(var)s, combined with the observation that
mutations in only two PcG loci suppress TPE, suggests that TPE
represents a silencing phenomenon that is mechanistically distinct
from the repression associated with either PEV or PcG silencing.
In addition, since these 25 new candidate Su(TPE)s had previously
been identified as loci involved in regulating euchromatic genes or
nuclear architecture, it is probable that this third silencing
mechanism is not restricted to the telomeres and may represent
a widely used epigenetic repressive system.
Results
Telomeric position effect (TPE) vs. centromeric position
effect variegation (PEV)
In order to compare and contrast PEV and TPE, we chose two
well characterized examples of each phenomenon. Both employ
the white (w
+) gene in D. melanogaster as a reporter to monitor the
repressive effects of telomeric (TPE) or centromeric (PEV)
chromatin.
Suppression of telomeric position effect (TPE). We tested
suppression of TPEby using the y
1 w
118; P [w
+] 39C-5 reporter stock
(39C-5), described previously [38,44,57]. This strain was chosen
because it is the strain that has been used to define and characterize
TPE. The 39C-5 strain bears a construct containing a mini-white
reporter gene, driven by an hsp70 promoter, embedded in the
telomere associated satellite-like repeats (TAS) [58] of the telomere
at the left arm of chromosome 2 (Figure 1A). In this location,
expression of the mini-white gene is strongly repressed and the eyes,
in stocks where the insert is heterozygous with a normal telomere,
display a uniform pale yellow phenotype with occasional red facets
(Figure 2); these eyes have about 3% of the pigment observed in
wild-type flies, measured spectrophotometrically. It is important to
note that the phenotype associated with 39C-5 is due to the
repressive effects of the telomere (TPE), since the same construct
inserted into euchromatin of the X chromosome, in the 39C-X
strain, gives fully pigmented, red eyes (data not shown and [38,57].
Wemonitoredtheeffectsofvariousmutationsand smalldeficiencies
on TPE in flies heterozygous for the 39C-5 insert by visually scoring
the amount of pigment. Suppression of TPE was scored as strong
(+++), moderate (++), weak (+), or no suppression (2), examples of
which are shown in Figure 2. In order to confirm our visual scoring
regime, we conducted pigment assays on selected TPE-suppressing
mutations and measured the levels of the eye pigment, drosopterin.
Strong suppression of TPE corresponded to drosopterin levels four
to five times higher, moderate suppression three to four fold higher,
Figure 1. The structure of the reporter construct and its location in the 2L telomere. A) The hsp70 promoter drives the mini-white gene.
Small arrows indicate the locations of the PCR primers. B) The reporter construct is inserted into the TAS sequences of the 2L telomere in the 39C-5
strain. The approximate size of the various regions and the location of the first known gene proximal to the telomere, l(2)gl, are indicated. Bold arrows
within genes indicate direction of transcription, bold arrows at the telomere indicate orientation of the Het-A elements.
doi:10.1371/journal.pone.0003864.g001
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control genotype, which is about 3%.
Suppression of position effect variegation (PEV). We
tested effects of various mutations on PEV using the inversion
strain In(1)w
m4 (w
m4) that is commonly used to monitor suppression
of PEV. The w
m4 stain has a large pericentric inversion of the X
chromosome with breakpointsjust distaltothew
+gene and inthe ß-
heterochromatin at the base of the X chromosome. The inversion
bringsthewild-type whitegene intocloseproximity(25–30 kb)tothe
ß-heterochromatin which results in a variegated pattern of eye
pigmentation (Figure 3). The levels of drosopterin found in the
normal w
m4 strains vary from 5 to 15% of that found in wild-type
eyes. Several screens have identified over 30 loci, called Su(var)s,
which, when mutated, cause very strong dominant suppression of
w
m4 [21,22,59], resulting in pigment levels greater than 50% of that
observed in the eyes of normal w
m4 flies. In the present experiments,
we visually scored suppression of PEV as strong (+++), moderate
(++), weak (+), or no suppression (2) (Figure 3). Pigment assays on
Su(var) mutations demonstrate that strong suppression corresponds
to drosopterin levels about six to ten fold higher (75–98% of the
amount found in wild-type strains), moderate suppression four to
five fold higher (50–75%) and weak suppression two to three fold
higher (30–50%), than that observed in the normal w
m4 strain.
Suppressors of PEV rarely suppress TPE. Only about 10
of the more than 30 Su(var) genes have been cloned thus far.
Many of these encode basic components of, or modifiers of,
chromatin such as: Heterochromatic Protein 1a [Hp1a, originally
Su(var)2-5] [27,28,30,60,61]; histone deacetylase 1 [Hdac1/RPD3,
originally Su(var)3-26] [24,62]; and the histone methyltransferase
Su(var)3-9 [25,26,31,63–65]. Almost all of the Su(var) genes that
have been cloned and characterized at the molecular level are
conserved in eukaryotes from yeast to humans.
Cloned Su(var)s. We began our analysis with seven Su(var)
genes that have been cloned and well-characterized at the
molecular level and for which, in most cases, we had multiple
alleles (Table 1).
1) Su(var)3-9:S U(VAR)3-9 is a histone H3 lysine 9 specific
methyltransferase. As noted above, Donaldson et al. (2002)
recovered a single allele of this gene that suppressed TPE.
We tested ten different mutant alleles of Su(var)3-9, all of
which have been sequenced. The nine missense mutations
occur in different regions of the protein, all alter the
HMTase activity, albeit to different degrees, and all are
strong dominant suppressors of PEV (Kalas et al.,
manuscript in preparation). Eight of the nine missense
mutations suppress TPE (Figure 2; Table 1) and, within this
group, the strength of TPE suppression varied from weak
[Su(var)3-9
376) to as strong as that observed with any single
gene mutation [(Su(var)3-9
330]. The single P-element inser-
tional mutation is located in the first exon of SU(VAR)3-9
protein and, while it is a strong suppressor of PEV [31], it
does not suppress TPE. In summary, the majority of the
Su(var)3-9 alleles, but not all, suppress TPE.
2) Hdac1/RPD3:H DAC1 is encoded by Su(var)3-26 and is a
histone deacetylase that removes acetyl groups from lysine
residues on both histones H3 and H4. Three different point
mutations in this gene exist, each of which causes a different
single amino acid substitution, and all are strong Su(var)s
[24]. We tested each of the three point mutants for their
effects on TPE. All alleles of Hdac1 suppressed TPE.
However, once again we observed allele specific differences;
Hdac1
326 is a very strong Su(TPE), while Hdac1
303 and
Hdac1
313 are weak Su(TPE)s (Table 1).
Figure 2. Suppression of TPE. A) Strong (+++) suppression of TPE by
the Su(z)2
5 allele. w
2/Y; reporter gene/CyO (left), and w
2/Y; reporter
gene/Su(z)2
5 sibling (right). B) Weak (+) suppression of TPE by the
Su(z)2De
26 allele. w
2/Y; reporter gene/CyO (left), and a w
2/Y; reporter
gene/Su(z)2De
26 sibling (right). C) HP1a mutations have no effect of TPE.
w
2/Y; reporter gene/CyO (left), and w
2/Y; reporter gene/HP1a sibling
(right) have identical pale yellow eyes.
doi:10.1371/journal.pone.0003864.g002
Figure 3. Suppression of PEV. A) Strong (+++) suppression of PEV by
Hp1a mutations. w
m4/w
2; +/CyO (left) and a w
m4/w
2; +/Hp1a sibling
(right). B) Strong to moderate suppression by an Hp1a deficiency. w
m4/
Y; +/CyO (left) and a w
m4/Y
2; +/Df(28E4-7;29B2-C1) sibling (right). C)
Moderate (++) suppression by a putative Lamin B Receptor homolog
(CG17952)d e f i c i e n c y .w
m4/w
2; +/CyO (left) and a w
m4/w
2; +/
Df(57F2;58A1) sibling (right).
doi:10.1371/journal.pone.0003864.g003
Table 1. Suppression of PEV and TPE by cloned Su(var)
genes.
Gene Allele Mutation PEV TPE
Su(var)3-9 3-9
06 null +++ ++
a
3-9
1 R493Q (SET domain) +++ ++
b
3-9
2A5 P element insertion +++ 2
3-9
309 C462Y (preSET domain) +++ ++
3-9
311 G521D (SET domain) +++ ++
3-9
318 S616L (postSET domain) +++ +
3-9
324 C428Y (preSET domain) +++ 2
3-9
325 P582Q (SET domain) +++ +
3-9
330 D536N (SET domain) +++ +++
3-9
376 C421S (preSET domain) +++ +
Hdac1 Hdac1
303 C98Y +++ +
Hdac1
313 R30C +++ +
Hdac1
326 P204S +++ +++
abo abo Point mutation + 2
b
HP1a Su(var)2-5
5 Point mutation +++ 2
c
Su(var)2-5
4 Point mutation +++ 2
Deficiency Df: 28E4-7; 29B2-C1 +++ 2
b
puc puc P element insertion +++ 2
b
Su(var)2-10 Su(var)2-10
2 Point mutation +++ ++
b
Su(var)2-10 Df: 45A6-7; 45E2-3 ++ ++
b
Su(var)3-7 Deficiency small deficiency +++ 2
a
Deficiency Df: 87E1; 87F12 +++ +
b
Unless otherwise indicated mutations were generated in this laboratory.
agift from G. Reuter.
bBloomington Stock Center.
cgift from J. Mason.
doi:10.1371/journal.pone.0003864.t001
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associates with the telomeres of some polytene chromo-
somes. Furthermore, FISH analyses in Su(var)2-10 mutant
strains revealed nuclei with defects in telomere clustering
and altered telomere–nuclear lamina associations [66]. We
tested one point mutation and one deficiency for the locus
and found both were moderate Su(TPE)s (Table 1).
4) Su(var)3-7:S U(VAR)3-7 is a protein of unknown function. It
contains an unusual, widely-spaced, zinc finger motif [67] and
localizes, primarily, to centromeric heterochromatin [68]. We
tested a small deficiency that only removes Su(var)3-7 and one
adjacent gene; it failed to suppress TPE. We also tested a
second, larger, deficiency that removes several genes including
Su(var)3-7, but it only weakly suppressed TPE. Therefore,
since the smaller deficiency did not suppress TPE, we believe
that Su(var)3-7 is not dosage sensitive with respect to
suppression of TPE (Table 1).
5) Hp1a:H P1A is a chromatin structural protein conserved
from yeast to humans. We tested two point mutations and a
deficiency for Hp1a, but none of these suppressed TPE
(Table 1) confirming the results of Cryderman et al. [38].
Recently, other groups have shown that HP1a localizes to
Drosophila and mammalian telomeres and that mutations in
Hp1a increase the frequency of telomere fusions and cause
increased transposition rates of both HeT-A and TART
elements [69,70]. Thus, although HP1a is present at the
telomere and involved in the capping and transposition
functions, mutations in this gene do not affect the silencing
observed in TPE.
6) abnormal oocyte (abo):A BO localizes to the histone gene cluster
and is a negative regulator of histone transcription [71]. A
mutation in abo was a moderate suppressor of PEV, but had
no effect on TPE (Table 1), although we only tested a single
point mutation.
7) puckered (puc):P UC contains a dual specificity protein
phosphatase domain that has a known role in the JNK
kinase pathway [72]. Mutations in puc are strong suppressors
of PEV (our unpublished observations). We tested one allele
that strongly suppresses PEV but it had no effect on TPE
(Table 1).
Uncloned Su(var)s (Table 2). The majority of Su(var)
mutations have not been cloned and thus remain
uncharacterized at the molecular level. However, we have
positioned 23 uncloned Su(var) mutations by recombination
mapping. The mutations are homozygous viable and have no
morphologically distinct recessive phenotypes making it impossible
to place them into complementation groups, but recombination
mapping indicates that they cluster around eight distinct regions
(Table 2). It is common for several different Su(var) genes to be
found within a few map units of one another [19,21,22,73], thus it
is possible these mutations represent as many as 23 different
Su(var) genes, but even under the most conservative estimates,
they represent at least eight distinct loci. All 23 mutations are
strong suppressors of PEV, but none affected TPE. Thus, either all
23 Su(var) genes do not influence TPE, or to take a far more
conservative interpretation, if these 23 mutations represent only
eight distinct loci, each with multiple alleles, then none of the eight
Su(var) loci suppress TPE.
Summary. Of a minimum of 15 Su(var) loci examined, and
possibly as high as 30, only three of the Su(var) mutations, or 10 to
20%, also suppressed TPE. This suggests that the mechanisms
underlying PEV and TPE differ substantially. Furthermore, these
results suggest that pre-existing libraries of Su(var) mutations are
unlikely to contain significant numbers of TPE-suppressing
mutations.
Known Su(TPE) mutations do not suppress PEV
Previously known Su(TPE) (Table 3). Prior to this study
only five Su(TPE) loci had been identified in Drosophila:
1) ataxia telangiectasia mutated (atm): atm is a protein kinase
involved in a variety of cellular functions from receptor
signaling to chromatin organization and biogenesis. A single
mutation in atm was shown to suppress TPE [54], but
whether it has an effect on PEV has not yet been
determined.
2) grappa (gpp): gpp is a histone lysine methyltransferase specific
for K79 of histone H3. Shanower et al. [55] tested several
alleles of gpp for their ability to suppress TPE and PEV. As is
the case with other Su(TPE)s, considerable allele-specific
variation in strength of suppression of TPE was observed.
However, none of the alleles they tested suppressed PEV,
although they did display both Polycomb Group and
Trithorax Group phenotypes.
3) Polycomb Group Genes –Posterior sex combs (Psc) and
polyhomeotic (ph): Psc is a Polycomb Group member with
DNA binding activity involved in chromatin remodeling and
Table 2. Suppression of PEV and TPE by Su(var) mutations
that have not been cloned.
Su(var) Location PEV TPE
2nd Chromosome
208 5.7 +++ 2
211 6.2 +++ 2
204 33.8 +++ 2
209 35.4 +++ 2
2-1 40.5 +++ 2
a
201 ‘‘ +++ 2
210 ‘‘ +++ 2
213 ‘‘ +++ 2
214 ‘‘ +++ 2
215 ‘‘ +++ 2
206 51.3 +++ 2
212 64.2 +++ 2
203 65.7 +++ 2
3rd Chromosome
3-3 46.6 +++ 2
a
304 ‘‘ +++ 2
307 ‘‘ +++ 2
316 ‘‘ +++ 2
327 ‘‘ +++ 2
321 47.6 +++ 2
323 47.3 +++ 2
333 49.8 +++ 2
301 55.5 +++ 2
305 56.8 +++ 2
Unless otherwise indicated all mutations were generated in this laboratory.
agift from G. Reuter.
doi:10.1371/journal.pone.0003864.t002
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mutations in Psc function as suppressors of TPE [38,44,57]
(but see Mason [45]), we tested five alleles of Psc in the same
genetic background to minimize the effects of possible
second site mutations or other genomic modifiers. All of the
Psc mutations had strong homeotic phenotypes, but varied in
their ability to suppress TPE. Three of the five alleles
suppressed TPE, in agreement with the results of Cryder-
man et al. [38]. However, as shown by Mason et al. [45],
Psc
1 did not suppress TPE. A fifth allele, Psc
h27, also failed to
suppress TPE. Since three of the five alleles tested
suppressed TPE we believe Psc is a bona fide Su(TPE) (see
Discussion). Importantly, none of the mutant alleles of Psc
suppressed PEV (Table 3).
3) The ph loci have also been implicated in modifying TPE.
They appear to have arisen by a gene duplication event that
created two paralogs, polyhomeotic proximal (ph-p)a n d
polyhomeotic distal (ph-d)t a n d e m l yr e p e a t e do nt h eX
chromosome. Boivin et al. [44] identified a mutation in
ph-p (ph
410, an inversion that disrupts ph-p, but not ph-d)a sa
Su(TPE). We tested a second inversion that only disrupts ph-
p (ph
409), but it did not suppress TPE (Table S1). In contrast,
a small intragenic deficiency that creates a null mutation for
ph-d, but does not affect ph-p, [74] was a strong suppressor of
TPE (Table S1). Since both PH-P and PH-D localize to the
telomeres of 2L and 3L [6], it is possible that one or both
proteins are involved in TPE, however, confirmation will
require further analysis (see below). Mutations in either of
these loci do not suppress PEV.
4) Su(var)3-9 [43] and this study, see above.
5) Suppressor of zeste (2) [Su(z)2]: Su(z)2 is a DNA binding
transcription factor [75]. We tested five alleles of Su(z)2 and
found that four out of five mutant alleles of Su(z)2
suppressed of TPE (Table 3). Like other Su(TPE) loci, the
three Su(z)2 point mutations varied in the strength of their
suppression of TPE. The Su(z)2
1.a1, and Su(z)2
De26 mutations
were weak suppressors of TPE and the Su(z)2
1.b7 mutation
was a moderate suppressors of TPE. The Su(z)2
5 mutation,
which is actually a small deletion, was indeed a strong
suppressor of TPE, in agreement with Cryderman et al.
[38] and Wallrath and Elgin [57]. None of the Su(z)2 alleles
modified PEV.
Su(z)2
5 encompasses 4 distinct Su(TPE) loci. The Su(z)2
5
mutation is actually a small deletion that removes both Su(z)2 and
Psc [76]. We confirmed that point mutations in Su(z)2 and some
point mutant alleles of Psc function as suppressors of TPE. The fact
that Su(z)2
5 mutation removes both of these loci may account for
its strength. However, since several Su(var) loci are sometimes
found in close proximity to one another (refs), we tested the
possibility that Su(TPE)s may also be clustered by dissecting the
Su(z)2
5 deficiency in greater detail.
We tested 21 mutant alleles of genes that had been mapped to
polytene bands 49D-50C, which includes the region deleted in
Su(z)2
5, for their ability to complement Su(z)2
5 (Table 4) and for
their for their ability to suppress PEV or TPE. Our complemen-
tation tests identified 10 genes that are removed by the Su(z)2
5
deficiency, including both Psc and Su(z)2. Surprisingly, two
additional loci deleted by Su(z)2
5, Suppressor of zeste (3) [Su(z)3]
and Origin recognition complex subunit 3 (Orc3, also called latheo), are
also Su(TPE)s. In fact, point mutations in these genes are stronger
suppressors of TPE than point mutations in the Su(z)2 gene. Thus,
the Su(z)2
5 deficiency actually removes four independent TPE-
suppressing loci, which probably accounts for its unusual strength.
Neither of the newly identified Su(TPE)s, Su(z)3 or Orc3, had any
effect on PEV. Thus, even though mutations in Su(z)2, Psc, Su(z)3
or Orc3 genes represent some of the stronger suppressors of TPE,
Table 4. Complementation and Suppression analyses of
region 49D–E.
Mutant Allele
Complements
Su(z)2
5
Suppresses
PEV
Suppresses
TPE
bic
1 yes 22
Aats-asp
1 yes 22
l(2)49Dc
3 no 22
Psc
1.d20 no 2 ++
Su(z)2
1.a1 no 2 +
Su(z)3
1 no 2 ++
Su(z)3
eos no 2 ++
Orc3/lat
1 no 2 +J
Orc3/lat
6 no 2 ++
Dp
49Fk-1 no 22
l(2)49Ff
1 no 22
l(2)49Fj
1 no 22
l(2)49Fl
1 no 22
l(2)49Fm
3 no 22
sie
1 yes 22
l(2)49Fa
1 yes 22
l(2)49Fb
4 yes 22
seq
vr5-5 yes 22
l(2)49Fg
1 yes 22
l(2)49Fh
1 yes 22
l(2)49Fp
32 yes 22
cnn
HK21 yes 22
Cp1
llcnbw38 yes 22
All strains obtained from the Bloomington Stock Center.
doi:10.1371/journal.pone.0003864.t004
Table 3. Suppression of PEV and TPE by other known
Su(TPE)s.
Gene Allele PEV TPE
Psc Psc
1 22
Psc
1.d19 2 +
a
Psc
1.d20 2 ++
Psc
e22 2 ++
Psc
h27 22
Su(z)2 Su(z)2
1 22
Su(z)2
1.a1 2 +
Su(z)2
1.b7 2 ++
Su(z)2
5 2 +++
ab
Su(z)2
De26 2 +
a
Unless otherwise indicated all strains are point mutations obtainedfrom the
Bloomington Stock Center.
agift from T. Wu.
ba small deficiency.
doi:10.1371/journal.pone.0003864.t003
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four of these genes, cause suppression of PEV.
A candidate screen for Su(TPE)
Our goal was to determine whether the silencing phenomena of
PEV and TPE overlap significantly in mechanism and function, or
actually represent distinct silencing phenomena. Since, prior to
this study, only five Su(TPE) loci were known and we had only
been able to identify two additional Su(TPE) from our analysis of
Su(var)s and two from our analysis of the Su(z)2
5 deletion, we
undertook a screen designed to identify mutations that suppressed
TPE. Each new candidate Su(TPE) was also tested for its ability to
suppress PEV in order to determine the extent of the overlap
between TPE and PEV. Rather than performing a random
mutagenesis screen we undertook a candidate screen using pre-
existing mutations and deficiencies. We selected single gene
mutations in, or deficiencies for, genes we believed might be
involved in the establishment or remodeling of chromatin
structure. These genes were selected based on information derived
from studies done in several organisms including yeast and
mammalian cells. Genes of interest included those that encoded:
chromodomain-containing proteins; chromatin-associated pro-
teins; proteins involved in nuclear structure including nuclear
attachment and nuclear pores; and, proteins already known to be
associated with telomeres or involved in telomere capping
functions. Where possible we tested point mutations of the genes
in question. In cases where point mutations were not available, we
tested the smallest deficiencies available that deleted the candidate
gene. In addition, wherever possible, multiple overlapping
deficiencies of the same loci were tested. Prior to testing, all
mutations were out-crossed for several generations to a strain
bearing an X chromosome that carried a null mutation of the w
gene and then crossed to our 39C-5 bearing strain. This protocol
created a uniform background against which to test our candidate
Su(TPE) and minimized the effect of possible second site
mutations and/or other genetic background effects on the
interpretations of our results.
In total, we examined 95 candidate loci. A detailed rationale for
why these loci were selected for testing and the complete data set
of the results of the candidate loci screen can be found in
Supplementary Materials Tables S1–S3. We will summarize the
positive results here and the reader is encouraged to examine the
detailed results in the Supplementary Materials that accompany
the manuscript.
Of special note were the chromodomain-containing proteins.
We tested mutations in, or deficiencies for 13 of these proteins
(Table 5). Surprisingly, all modified one, and usually only one, of
the three silencing phenomena considered here. For example, a
mutation in Pc causes homeotic transformations but does not
suppress TPE or PEV, mutations in Hp1a only suppress PEV (this
study and [38]), and mutations in kis only suppress TPE.
Mutations in Su(var)3-9 are an exception because they strongly
suppress both PEV and TPE, however they do not cause homeotic
transformations. The small deficiency that removes both Mi-2 and
CHD3 suppresses TPE and PEV. It is quite possible that each of
these loci is involved in suppression of only one silencing
phenomenon, either PEV or TPE, but this will require further
analysis.
Point mutations that suppress TPE. Employing point
mutations, or a combination of point mutations and deficiencies,
our analysis identified four new Su(TPE)s (Table 6):
1) male sex lethal 3 (msl3): This chromodomain-containing
protein is an essential member of the dosage compensation
Table 5. Suppression of PEV and TPE by Chromodomain
Proteins.
Gene Allele Type of Mutation PEV TPE
Su(var)3-9 Su(var)3-9
330 Point mutation +++ +++
HP1a Su(var)2-5
4 Point mutation +++ 2
Su(var)2-5
5 Point mutation +++ 2
Df(2L)28E4-7;29B2-C1 Deficiency ++ 2
CG8120
a Df(3R)85D8-12; 85E7-F1 Deficiency 2 +
Df(3R)85D10-12; 85E1-3 Deficiency 2 +
HP1c
a Df(3R)93E-F; 94C-D Deficiency 2 ++
CG15636
a Df(2L)24C2-8;025C8-9 Deficiency ++ 2
Chro Df(3L)79E2+;80; 70D1-2 Deficiency +++ 2
msl-3 msl-3
1 Point mutation 2 +
MRG15 Df(3R)88E7-13; 89A1 Deficiency 2 +
kis kis
1 Point mutation 2 +
Df(2L)21A1; 21B6-7
PMC Deficiency 2 ++
Df(2L)21A1; 21B6-7
PM47C Deficiency 2 ++
Chd1 Df(2L)23C1-2; 23E1-2 Deficiency + 2
Mi-2 Df(3L)76B; 77A
b Deficiency ++ +
CHD3 Df(3L)76B; 77A
b Deficiency ++ +
Pc Pc
1 Point mutation 22
aCG8120, HP1c,a n dCG15636 also have chromo shadow domains and are
putative paralogs of HP1a.
balso removes Kap-a1 (see Table 7).
doi:10.1371/journal.pone.0003864.t005
Table 6. Summary of PEV and TPE suppression by single
gene mutations tested in this screen.
PEV only TPE only TPE and PEV Neither
Abo kis
a Hdac1
a Asx
Fs(2)Ket msl-3
a Su(var)2-10
a dpa
HP1a Psc Su(var)3-9 Ez
Orc2 Orc3 (lat)
a H2AvD
puc Su(z)2 mle
Su(var)2-1 Su(z)3
a mus306
Su(var)203 mus307
Su(var)204 Nup98
Su(var)206 Orc5
Su(var)208 Pc
Su(var)209 ph-p
Su(var)211 a-Tub84B
Su(var)212 b-Tub85D
Su(var)3-3 UbcD1
Su(var)3-7
Su(var)301
Su(var)305
Su(var)321
Su(var)323
Su(var)333
Total=20 Total=6 Total=3 Total=14
anew Su(TPE) identified in this report.
doi:10.1371/journal.pone.0003864.t006
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on the X chromosome [77]. MSL3 and HDAC1 interact and it
has been suggested this interaction is essential for the
spreading of the DCC on the X chromosome [78]. Since
HDAC1 is also required for efficient silencing at the telomere
it is possible that HDAC1 and MSL3 interact at the telomere,
perhaps for the spread of a structure required for the
silencing observed in TPE. Mutations in mls3 did not
suppress PEV. Since HDAC1 is also required for silencing
PEV, the potential HDAC1 and MSL3 interaction is either not
sufficient for silencing in general, or the distribution of this
complex is spatially constrained, or compartmentalized,
within the nucleus.
2) kismet (kis): We tested three mutations of the kis locus, a point
mutation and two small deficiencies, and all three suppress
TPE (Table 5). The kismet gene encodes a chromodomain
containing protein. It was originally classified as a member
of the Trithorax Group (TxG) of transcriptional activators
and is related to members of the SWI2/SNF2 and CHD
families of ATP-dependent chromatin-remodeling factors
[79]. Thus one might not expect it to be involved in a
silencing mechanism like TPE. However, it also co-localizes
with the transcriptional repressor complex Mi-2, which also
contains HDAC1 [80]. Therefore kis may be involved in both
activation and repression. The mutations did not suppress
PEV.
3) Origin recognition complex subunit 3 (Orc3 also known as latheo):
We have tested two alleles of Orc3 and both suppress TPE,
but do not influence PEV (Table 4). Orc3 is a component of
the origin replication complex and thus may be involved in
the establishment of chromosome structure during replica-
tion [81]. Additionally, a null mutation in Orc3 results in
cessation of cell division in 3
rd instar larvae, a phenotype
consistent with telomeric defects [81].
4) suppressor of zeste3[ su(z)3]: Mutations in this gene dominantly
suppress the eye phenotye associated with zeste mutations
[76]. This gene has not been cloned and thus its molecular
function is unknown. We tested two alleles of this gene and
both are strong Su(TPE)s, but neither influence PEV.
During the course of the screen we tested 90 point mutations
representing 43 different loci and identified four new Su(TPE)
(Table 6). None of these mutations suppressed PEV or are PcG
members, which further underscores the differences between
telomeric, centromeric and polycomb gene repression. We believe
all four of these newly identified Su(TPE)s are bona fide for three
reasons. First, almost all were confirmed with either more than one
point mutation or a combination of a point mutation and a
deficiency. Second, where multiple alleles exist for a candidate
locus, the various alleles were often recovered in screens conducted
in different labs and thus are not likely to carry an identical second
site mutation that is the actual Su(TPE). Third, and importantly,
these loci were identified through an out-crossing protocol that
minimized the effect of genetic background and possible second
site mutations. Consequently, we are convinced these genes likely
code for proteins that are either structural components of
telomeres or modify telomere structure.
Deficiencies that suppress TPE. We tested a total of 85
deficiencies that removed 52 candidate loci for their effects on
TPE and PEV (summarized in Table 7). The deficiency strains
were put through the same mating protocol as the point mutations
to reduce or eliminate background effects. We identified ten
deficiencies that only suppressed TPE and ten that suppressed
both TPE and PEV. Each of the deletions in the latter group may
remove a locus common to both phenomena or may delete one
locus that suppresses TPE and one that suppresses PEV.
We believe that each of the deletions that suppress TPE
removes one, or more, dosage-sensitive loci involved in creating or
modifying telomere structure. We acknowledge that a deficiency
can only identify the region where one, or more, dosage sensitive
loci may reside, and thus requires further analysis to determine the
actual Su(TPE). For example, a deficiency for HP1c suppressed
TPE but had no effect on PEV (Table 5). We employed
chromatin-immunoprecipitation (ChIP) to demonstrate HP1c
was localized to the reporter gene when it was inserted at the
telomere but not to the identical reporter gene when it was
inserted into the euchromatin of the X chromosome (see below).
This result underlines the value of deficiencies for preliminary
screening.
In summary we identified 20 regions which may harbor
candidate Su(TPE)s., Although the putative Su(TPE) loci identi-
fied using small deletions need to be verified by further analysis, it
may be useful to very briefly describe some of the genes targeted in
those deletions that suppressed TPE only.
HP1c: HP1c is a paralog of HP1a [Su(var)2-5] [82]; nonetheless,
their chromosomal binding patterns are, for the most part, distinct
[34,82]. HP1a binds to centromeric heterochromatin and to the
termini of most chromosomes. While HP1c binds primarily to the
euchromatic regions of the chromosomes, it is also found at or
near the tip of most chromosomes. A deficiency for HP1c was a
moderate suppressor of TPE (Table 5). Using ChIP we confirmed
that HP1c binds to the reporter gene when inserted into the TAS
Table 7. Summary of loci identified solely by deficiencies.
TPE only PEV only TPE and PEV Neither
CG6678 CG5467 CG13560 CG2158
CG8120 CG9696 CG14712 CG6995
CG8149 CG10712 CHD3
a CG8219
c
H3.3 CG14692 Irbp
b CG10478
c
HP1c CG15636 Kap-a1
a CG30122
Kap-a3 CG17952 mbo BEAF-32
MRG15 CG31901 Mi-2
a Bj1
Mt2 Chd1 Mt2 gcl
Nup44A Chro mus309
b Iwr
Nup154 His-C Ranbp9 Karyb3
cTub23C lamC
lamin
Mcm7
Mtor
mus210
Nup358
Ote
Ranbp11
Spt4
tou
Trn
c
Total=10 Total=11 Total=10 Total=21
aremoved by same deficiency.
bremoved by same deficiency.
cremoved by same deficiency.
doi:10.1371/journal.pone.0003864.t007
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when inserted into euchromatin (see below), providing molecular
confirmation that mutations in Hp1c are Su(TPE)s.
MRG15: The human MRG15 and its Drosophila homolog
Dmel/MRG15 (CG6363) contain an N terminal chromodomain
that is believed to play a role in chromatin remodeling and
transcriptional regulation. The N terminal chromodomain binds
to meythylated Lys26, but not methylated Lys4, Lys9 and Lys27 of
histone H3 [83,84]. A deficiency for the region encompassing
Dmel/MRG15 was a weak suppressor of TPE and had no affect on
PEV (Table 5).
Histone H3.3A (H3.3A): H3.3A is a variant form of histone H3
and is found associated with actively transcribed genes or ones that
were recently transcribed [85–87]. A deficiency for the region
encompassing H3.3A suppresses TPE weakly and does not
suppress PEV (Table S1).
Nup44A and Nup154: We tested deficiencies for 13 Drosophila
genes that encode nuclear pore proteins or are homologs of the
yeast nuclear pore proteins. Deficiencies for Nup44A (44A) or
Nup154 (35C–D) were weak suppressors of TPE (Table S2); they
have no affect on PEV.
DmelMT2 (Mt2): While DNA methylation is a primary mark of
silenced genes in mammals, there is very little DNA methylation in
Drosophila. The Mt2 gene represents the only known DNA
methylase in Drosophila and it appears to encode a novel CpT/A-
specific DNA methyltransferase protein, that functions as a
genuine cytososine-5 methyltransferase [88]. Its function in
Drosophila is unknown, but it is required for the maintenance of
normal life. Hemizygosity for a region encompassing the Mt2 is a
moderate suppressor of TPE and has no affect on PEV (Table S1).
CG6678: CG6678 contains an RCC1 domain (regulator of
chromatin condensation) (Flybase: http://flybase.bio.indiana.edu).
Proteins containing an RCC1 domain are believed to be involved
in altering chromatin structure and modifying gene expression. A
deficiency removing CG6678 was a weak suppressor of TPE (Table
S1) and had no affect on PEV.
We also found 10 deficiencies that suppress PEV only and 10
that suppress both PEV and TPE. These deficiencies may identify
the location of as many as 20 new Su(var) loci, representing a
substantial increase in the number of genes involved in the
mechanism underlying PEV.
The deficiencies identified here require further analysis,
employing ChIP, or smaller deletions, point mutations or P
element inserts into the genes removed by the deficiencies to
determine which specific loci are involved. Nonetheless, these
deficiencies identify target areas that merit further genetic and/or
molecular dissection investigation.
Chromatin immunoprecipitation (ChIP). In order to
support our hypothesis that the candidate loci were involved in
TPE, and not the result of a second site mutation, we could have
recombinationally mapped the Su(TPE) phenotype in an attempt
to confirm it co-localized with the mapping of the candidate gene.
We did not employ recombination mapping for three main
reasons. First, it is very difficult to find multiply marked
chromosomes suitable for recombination mapping, that do not
modify TPE ( [45] and our unpublished observations). Second, the
phenotype of TPE is quite variable within a population, even those
bearing a Su(TPE) mutation, which undermines the precision of
any recombination based data. Third, recombination mapping
does not address the question of whether the Su(TPE) gene
product influences the chromatin structure of the telomere directly
or indirectly. Instead, we employed ChIP to determine whether
the protein product of the candidate genes localized to specific
sequences of the reporter construct when it was inserted into the
telomere and subject to TPE, but was absent from the identical
regions of the same reporter construct when it was inserted into
the euchromatin of the X chromosome in the 39C-X strain, where
the construct is fully expressed.
We conducted ChIP analysis on 3 Su(TPE) candidate proteins,
HDAC1, SU(VAR)3-9 and HP1c and a control, the Su(var) protein,
HP1a, which is not involved in TPE ( [38] and this study). HDAC1
was chosen because all 3 single bp missense mutations suppressed
TPE. SU(VAR)3-9 was chosen because nine of the eleven mutations
tested suppressed TPE. Finally, HP1c was chosen because it was
identified as a moderate Su(TPE) using deficiency analysis alone
(see above) and thus served as a test of the validity of the using
small deletions to identify genes to identify Su(TPE) loci. ChIP
extracts were prepared from the 39C-5 (telomeric insert) and the
39C-X (euchromatic insert) strains and protein-nucleic acid
complexes were precipitated with antibodies specific for HDAC1
and HP1c. We determined the distribution of SU(VAR)3-9 with a
SU(VAR)3-9:GFP fusion protein. The distribution of the fusion
protein has been shown to mimic the distribution of the native
SU(VAR)3-9 protein [89]. The line bearing the fusion protein was
crossed to the 39C-5 and the 39C-X strains and the ChIP extracts
were immunoprecipitated with an antibody specific for GFP.A sa
negative control we employed an antibody specific for HP1a,
which localizes to telomeres but is not a Su(TPE). We employed
primers spanning the hsp70 promoter/w
+ coding region (Figure 1),
and thus specific for the reporter construct, and real-time PCR to
determine the relative abundance of these proteins at the reporter
when it was inserted in the telomere or euchromatin. The results
show that the Su(TPE) candidates, HDAC1, SU(VAR)3-9 and HP1c,
are all present in abundance when the construct is inserted at the
2L telomere and the w
+ gene is silenced (Figure 4). However, only
background levels are observed when the reporter construct is
inserted into euchromatin where the w
+ gene is fully expressed. In
contrast, HP1a is not found at the reporter in either strain,
confirming that while it may localize to telomeres, it is not found at
a the silenced construct and is thus is unlikely to be involved in
TPE. These results suggest HDAC1, SU(VAR)3-9 and HP1c are not
only required for the silencing associated with TPE, but act
directly on the construct to silence gene expression. Finally, these
results validate our genetic approach to identifying genes that
participate in the mechanism underlying TPE.
In summary we have increased the number of Su(TPE) from
five to 12: two from our existing library of Su(var)s; two from our
analysis of point mutations in loci deleted by the small deficiency
Su(z)2
5; two from point mutations tested in our candidate screen;
and, one from our deficiency screen that was confirmed by ChIP.
Our deficiency screen identified an additional ten regions that
harbor one or more Su(TPE)s and ten that delete loci that suppress
both PEV and TPE. Finally, we have identified an additional
eleven regions that delete one or more genes that suppress PEV
only.
Discussion
Two gene silencing phenomena, PEV and PcG repression, have
been extensively studied and their analysis has provided insights
into two distinct repressive mechanisms employed in most
eukaryotes. We have previously shown that there is very little
overlap between suppressors of PEV and the PcG of proteins [36].
Telomeric position effect or TPE is another silencing phenome-
non, but it that has remained relatively uncharacterized. One of
the goals of this study was to determine the overlap between TPE
and PEV and to extend the studies on the overlap between TPE
and PcG.
Telomeric Position Effect
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TPE
Previously [38,44], and in this study, a large number of the PcG
proteins were tested for their ability to modify TPE. Only one PcG
member clearly suppresses TPE, Psc (this study). Mutations in the
ph cluster may be Su(TPE), but the evidence is inconclusive ( [44],
this study). Thus PcG silencing appears to differ significantly from
TPE silencing.
Su(var)s don’t generally suppress TPE
Until this study, no systematic attempt has been made to
determine whether suppressors of PEV would also suppress TPE.
The phenotypes of TPE and PEV are very similar, and thus, it
seemed likely that there would be a significant overlap between
modifiers of PEV and TPE. Accordingly, we tested between 15
and 30 different Su(var)s (see Results for a discussion of this range)
for their effect on TPE. Surprisingly, only three Su(var)s, or 10–
20%, are also Su(TPE)s. The three Su(var)s that affect TPE are
Su(var)3-9 ( [43] and this study), Hdac1 and Su(var)2-10. Su(var)3-9
and Hdac1 are enzymes that modify histone tails. Their
participation in both TPE and PEV suggests that modification
of nucleosome structure may be an early step in the process
leading to the gene silencing observed in both phenomena. The
function of Su(var)2-10 is unknown, but the protein has been
localized to telomeres [66] and therefore it is likely the SU(VAR)2-10
protein is directly involved in the silencing process. However, the
large majority of mutations that suppress PEV have no effect on
TPE. This suggests that, while TPE and PEV may share a small
number of components, the two gene silencing systems differ
mechanistically. Furthermore, these data suggest that chromatin
structure at the telomere, for the most part, differs from the
structure of centromeric heterochromatin. Thus, screening other
libraries of Su(var) mutations is unlikely to provide many
additional components of telomeres and suggests that in order to
more completely identify chromatin proteins that comprise or
remodel telomeres, one must conduct screens based on specific
telomere associated phenotypes.
A candidate screen for Su(TPE)
Prior to this report, only five loci had been identified in
metazoans that, when mutated, suppress TPE: Psc; Su(z)2 [38];
Su(var)3-9 [43]; atm [54] and gpp [55]. The survey of our Su(var)
collection increased the number of Su(TPE)s to seven and our
analysis of Su(z)2
5 added two more, Su(z)3 and Orc3 (lat). However,
we were confident this was a rather large underestimate of the
proteins involved in establishing the structure that silences
constructs inserted into the telomere. Accordingly we undertook
a candidate screen for Su(TPE)s loci to identify additional
components of telomeres.
During the course of the candidate screen, we examined 90
point mutations that represent a minimum of 43 different loci
(summarized in Table 6), and 85 deficiencies representing 52
candidate loci (summarized in Table 7). Where possible, loci were
tested with multiple point mutations or a combination of point
mutations and deficiencies. In addition to determining whether
these mutations suppressed TPE, we also asked whether they
influenced PEV.
The point mutation screen identified two loci in which point
mutations suppressed TPE: msl-3 and kis (summary Table 5). None
of these mutations suppressed PEV, again, underlining the
differences between telomeric and centromeric silencing mecha-
nisms. Thus, including the Su(var) loci identified that also function
Figure 4. ChIP analysis of the reporter construct. Relative fold increase of various chromatin proteins at the reporter construct compared to IgG
controls when the reporter construct is inserted into the telomere (grey) or euchromatin (white). The results are from at least three separate
experiments and the error bars indicate 95% confidence limits.
doi:10.1371/journal.pone.0003864.g004
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through point mutations (in most cases tested with multiple alleles)
from 5 to 11. We believe these newly identified Su(TPE)s are bona
fide for two reasons. First, almost all were confirmed with either
more than one point mutation or a combination of a point
mutation and a deficiency. It is unlikely that multiple alleles of a
single gene, often isolated in different labs, would all have a second
site mutations that are Su(TPE)s. Second, these loci were identified
through an out-crossing protocol that minimized the effect of
genetic background and possible second site mutations. Conse-
quently, we are convinced these genes code for proteins that are
either structural components of telomeres or modify telomere
structure.
We note that there were often allele specific variations among
many of our newly identified Su(TPE) loci. This is not a novel
finding. Indeed, allele specific affects were noted with previously
identified suppressors of TPE [38,45,55]. The simplest, and most
likely, explanation for the variable expressivity of many, if not all,
of the Su(TPE) loci is that these loci were not selected as dominant
suppressors of TPE. Instead, all of these mutations were initially
discovered because they affected other biological phenomenon,
such as suppression of the zeste phenotype [Su(z)2], dosage
compensation (msl-3), or alteration of homeotic gene expression
(Psc). Since these genes were not selected originally as Su(TPE),
one would expect the various alleles to differ in expressivity, and
even penetrance, when examined for their influence on TPE.
Indeed, it would be surprising if they didn’t.
We examined 85 deficiencies for their effects on either TPE or
PEV (summarized in Table 7). We identified ten regions that
suppress TPE only, eleven regions that suppress PEV only, and ten
regions that suppress both TPE and PEV. The use of deficiencies,
even small ones, as we did here, to screen for candidate loci for
dosage sensitive effects on TPE or PEV requires some additional
comment. The major question is how reliable are these data; how
much confidence can be place in the observation they identify one
or more loci whose product levels are dosage sensitive for either
TPE, PEV or both?
Using a Drosophila ‘‘deficiency kit’’, Mason et al. [45] canvassed
approximately 75% of the genome for Su(TPE)s. Many of regions
he initially identified as containing a Su(TPE) were discarded for
one of four reasons: 1) the suppression of TPE was weak; 2)
multiple deficiencies for the same region gave discordant results,
that is, some suppressed while others did not; 3) recombination
analysis revealed the Su(TPE) did not map to the deficiency; or 4)
the deficiency in question either failed to complement the last
known locus on 2L, l(2)gl, or did not hybridize a probe for the 2L
telomere suggesting the chromosome had a 2L tip deficiency
which was assumed to be the real Su(TPE). However, many of our
Su(var)s also fail to complement l(2)gl (unpublished observations),
but do not suppress TPE. Thus, failure to complement l(2)gl does
not correlate with suppression of TPE and is not diagnostic for a
tip deficiency. Therefore it is not always a reliable criterion for
discarding potential Su(TPE).
The ‘‘deficiency kit’’ employs large deletions to allow rapid
screening of the majority of the genome, with a minimum of strains
and crosses. While convenient, the removal of large portions of the
genome in a single strain can produce conflicting results. It is
important to keep in mind that two or more Su(TPE) loci may be
closely linked and even small deficiencies may remove more than
one modifier of TPE. Indeed, we found an example of this clustering
with the small deficiency Su(z)2
5.A tm o s t ,Su(z)2
5 removes 14 bands
(,300–350 kb), and yet it deletes four Su(TPE)s. In this study, we
employed the smallest possible deletions that removed the candidate
locus and, where possible, used overlapping deletions. We
disregarded those deficiencies where the overlapping deletions gave
contradictory results or where the phenotype was too weak to be
reliably scored. We believe the data provided by our deficiency
analysis is valuable and provides a starting point for the search for
additional Su(TPE). For example, our deficiency analysis suggested
Hp1c was a Su(TPE), and ChIP analysis confirmed HP1c is a
chromatin protein that is located at the silenced reporter construct.
Accordingly, the deficiency results require additional analysis
employing ChIP, point mutations, the P element insertions currently
being generated by the Drosophila community and smaller deletions
as they become available.
When we began this study, a survey of the D. melanogaster
genome revealed 13 proteins containing chromodomains. We
examined mutations in, or deletions for, all 13 chromodomain
containing proteins (Table 5). Surprisingly every member of this
class was either a Su(TPE), a Su(var) or a PcG member. Thus, it
may be that all chromodomain proteins are involved in the
repression of gene expression and further that, in most cases, their
activity is restricted to one of the three silencing systems.
In total, our screen has increased the number of candidate
Su(TPE) loci from 5 to 30 loci, 6 by point mutations and 19 via
deletion analysis (Table 8). We believe 30 loci is still an
underestimate of the number of loci involved in TPE for a
number of reasons. First, our candidate screen did not include
genes on the X chromosome, which contains approximately 20%
Table 8. Summary of TPE-suppressing loci.
Function/Domain Point mutation Deficiency
Chromodomain kis CG8120
msl-3 CHD3
HP1c
Mi-2
MRG15
Chromatin-associated atm
a CG6678
Mt2
Histone modification Hdac1
gpp
a
Su(var)3-9
a
Histone variants H3.3
Nuclear import Kap-a1
Kap-a3
Ranbp9
Nuclear pore CG13560
CG14712
mbo
Nup44A
Nup154
Orc proteins Orc3 (lat)
PcG and Su(z) Psc
a
Su(z)2
a
Su(z)3
SAP domain Su(var)2-10 CG8149
yKu70/80 paralogs Irbp
mus309
agenes previously identified as Su(TPE)s by point mutations.
doi:10.1371/journal.pone.0003864.t008
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suspected of being involved in chromatin structure, nuclear
architecture, chromatin remodeling or metabolism at the time
we began the screen, and many more genes are now known to be
involved in establishing chromatin structure. Third, the 10
deficiency regions that specifically suppress TPE (Table 7) may
delete more that one locus that is involved in telomere structure, as
is the case with the small deficiency Su(z)2
5. Fourth, the 10
deficiency regions that suppress both TPE and PEV (Table 7), may
delete loci that are specific for each phenomenon. Finally,
deficiency screens can only identify dosage-sensitive loci, and thus
will miss loci that do not have a haplo-insufficient phenotype. A
clear example of this is provided by the results with the Hdac1
gene. We found that all three missense mutations in Hdac1
suppressed TPE; indeed one of the Hdac1 alleles (Hdac1
326) is the
strongest, or one of the strongest, Su(TPE) observed to date
(Table 2). Our previous data showed that the deficiencies that
delete Hdac1 do not suppress PEV [24] and Mason et al. [45]
demonstrated a deficiency for this region does not suppress TPE.
Hence, Hdac1 is not a dosage-sensitive locus. Deficiencies can only
identify dosage-sensitive loci, and not all Su(var) or Su(TPE) loci
are dosage sensitive.
Clearly, more work needs to be done to identify the components
of telomeres required for TPE. Nonetheless, we have provided a
large number of candidate loci for telomeric chromatin structural
or remodeling proteins.
The screen also identified an additional 23 candidate suppres-
sors of PEV: 2 by point mutation (Table 6) and 21 by deficiency
(Table 7). This almost doubles the number of candidate
suppressors of PEV identified in previous EMS and P-element
screens [21,22,59] and suggests, for the reasons outlined above,
that additional components of the PEV silencing system remain to
be identified.
We have examined the effects of the Su(TPE)s on a reporter
construct inserted into the TAS sequences of the left arm of the
second chromosome (2L). The TAS sequences vary among
chromosome arms and between individuals within a population
[48] and thus it is possible the effects of the mutations reported
here are restricted to 2L, but we think this is unlikely. It is the
repeated nature of the TAS sequences that is conserved
throughout eukaryotes, not the specific DNA sequences, suggest-
ing a common structural link between telomeres above the DNA
sequence level [48]. We predict the proteins identified here
participate in creating this chromatin structure at many or all the
telomeres within the fly and further, that this function will be
conserved in other eukaryotes. For example, immunostaining for
trimethylated H3K9, the product of SU(VAR)3-9, is found at all
telomeres [53].
At least three different gene silencing systems exist
The functions of the Polycomb Group and the Su(var) group of
proteins, two different gene silencing systems, are not restricted to
repressing homeotic genes or heterochromatic silencing respec-
tively. Rather, they are key components of silencing at many
euchromatic sites in the genome [1,31]. Since there is very little
overlap between the PcG and Su(var) groups of proteins it appears
they participate in two mechanistically distinct regulatory
processes and implies that at least two widely used repression
systems exist in eukaryotes.
Similarly, there is very little overlap between the Su(TPE) loci
identified in this paper and either the Polycomb Group or the
Su(var) Group of proteins. This suggests the Su(TPE)s represent a
novel group of regulatory proteins involved in gene silencing,
distinct from both the Polycomb and Su(var) groups of proteins.
We predict the Su(TPE) gene products will also be involved in
regulation of many loci within the euchromatic portion of the
genome. This is a relatively safe prediction, in part, because many
of the candidates chosen in the screen were not selected because
they were associated with telomeres, but because they were
known, or suspected, to affect chromatin structure, nuclear
architecture or chromatin metabolism at other sites in the
genome. Thus we predict, with considerable confidence, that
Su(TPE)s identify a third widely used gene repression system.
Materials and Methods
All crosses were performed at 22uC. Flies were grown on
standard cornmeal/sucrose medium supplemented with antibiotics
and 0.04% tegosept. Tegosept is used as a mold inhibitor rather
than propionic acid because the addition of propionic acid to the
growth medium suppresses PEV [90].
Some mutant and deficiency stocks were generated in our lab,
others were gifts from other investigators, but most were obtained
directly from the Bloomington stock center. The nature of the
mutations (point mutation, inversion or deficiency) and the
breakpoints of the deficiencies are listed in each table. Deficiency
stocks were chosen based on the cytological locations of the loci
being tested, as reported by the Berkeley Drosophila Genome
Project (BDGP) database (www.flybase.org and www.fruitfly.org).
Suppression of PEV was measured by expression of the w
+ gene
in the commonly used strain In(1)w
m4 (w
m4). Suppression of TPE
was monitored in the strain y
1 w
118; P[w
+] 39C-5,( 39C-5) [57] by
monitoring the effect of the various mutations on expression of the
mini-white gene from the reporter construct inserted into the 2L
telomere. In order to determine levels of white or mini-white gene
expression in both males and females, all mutations were crossed
into a w
2 background and backcrossed for several generations.
This had the added effect of placing all mutants (whether single-
gene, inversions or deficiencies) in a standardized genetic
background, thereby minimizing the effects of different genetic
backgrounds. The w
2 strain was used as one of the controls.
Suppression of TPE or PEV was scored in the w
2 background
by comparing expression levels of the reporter genes in a mutant
background to expression levels in their siblings, who received a
balancer chromosome rather than the chromosome bearing the
mutation of interest. Although some mutations are homozygous
viable, and therefore did not require the use of a balancer
chromosome to maintain the mutation in a w
2 background stock,
all stocks were selected to maintain the mutations over a balancer
chromosome, and these were employed for analysis. Thus, by
using temporarily balanced stocks of homozygous viable muta-
tions, it was still possible to use the balancer chromosome as a
control and maintain a standardized genetic background.
Suppression was scored as strong (+++), moderate (++), weak
(+), or no suppression (2) by visual inspection of the eyes, and by
comparison to balanced siblings. Eye pigment assays were carried
out on a selection of the crosses to confirm the correlation between
the visual scoring and the amount of drosopterin present in the
eyes.
Eye pigment assays
Eye pigment assays were carried out as follows. Flies were
placed in a glass screw cap tube, flash frozen in liquid nitrogen,
and then decapitated by vortexing. Ten heads were then placed
into a 1.7 ml microfuge tube with 200 mL of 0.1% ammonium
hydroxide. The heads were homogenized with 20 strokes of a
miniature Teflon pestle, sonicated with three five-second pulses of
a midi-tip sonicator set to 30% power output, and extracted
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centrifugation, and the absorbance of the aqueous phase was
measured in a spectrophotometer set to 485 nm, within the linear
range of the machine. Samples were extracted and measured in
quadruplicate.
Chromatin Immuno-precipitation (ChIP) Analysis
ChIP extracts were prepared according to previously published
protocols [31]. ChIP was used to contrast the distribution patterns
of HDAC1, SU(VAR)3-9:GFP, HP1a and HP1c in the reporter gene
located in the TAS sequences of the 2L telomere (39C-5) versus
the identical reporter gene located in the euchromatin of the X
chromosome (39C-X). Antibodies: a-HDAC1 (Abcam
TM ab1767-
100, rabbit IgG polyclonal); a-HP1a (C1A9 rabbit IgG monoclo-
nal; a gift from S. Elgin) and a-HP1c (rabbit polyclonal antisera; a
gift from S. Henikoff). The distribution pattern of SU(VAR)3-9 was
determined in a strain bearing a construct containing a SU(VAR)3-
9:Green Fluorescent Protein (GFP) fusion protein, a generous gift
from G. Reuter [89]. We employed an a-GFP antibody
(Molecular Probes
TM A-11122, rabbit IgG polyclonal). As a
control for non-specific immunoprecipitation we used an a-
bacteriophage T7-Tag antibody (Novagen 69522-3; rabbit IgG
monoclonal).
The amount of the fragment spanning the hsp70 promoter and
mini-white coding region of the reporter constructs precipitated
was determined with real-time PCR employing primers 5W3 (59-
AGT GAA CAC GTC GCT AAG CGA AAG) and 3W2 (59-
GGG ATT TTT GTG GGT CGC AGT TCT). The amount
precipitated from each construct bearing strain was normalized
with the Actin 42A locus employing primers 5A4 (59-TGT CTG
TGC GGT CAT TAT TAT TCC) and 3A12 (59-GAT CTT
CTC CAT GTC GTC CCA GTT).
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